These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 16929349

  • 1. Conserved extended haplotypes discriminate HLA-DR3-homozygous Basque patients with type 1 diabetes mellitus and celiac disease.
    Bilbao JR, Calvo B, Aransay AM, Martin-Pagola A, Perez de Nanclares G, Aly TA, Rica I, Vitoria JC, Gaztambide S, Noble J, Fain PR, Awdeh ZL, Alper CA, Castaño L.
    Genes Immun; 2006 Oct; 7(7):550-4. PubMed ID: 16929349
    [Abstract] [Full Text] [Related]

  • 2. Type 1 diabetes in the Spanish population: additional factors to class II HLA-DR3 and -DR4.
    Urcelay E, Santiago JL, de la Calle H, Martínez A, Méndez J, Ibarra JM, Maluenda C, Fernández-Arquero M, de la Concha EG.
    BMC Genomics; 2005 Apr 20; 6():56. PubMed ID: 15842729
    [Abstract] [Full Text] [Related]

  • 3. Exploring the diabetogenicity of the HLA-B18-DR3 CEH: independent association with T1D genetic risk close to HLA-DOA.
    Santin I, Castellanos-Rubio A, Aransay AM, Gutierrez G, Gaztambide S, Rica I, Vicario JL, Noble JA, Castaño L, Bilbao JR.
    Genes Immun; 2009 Sep 20; 10(6):596-600. PubMed ID: 19458622
    [Abstract] [Full Text] [Related]

  • 4. Type 1 diabetes risk for human leukocyte antigen (HLA)-DR3 haplotypes depends on genotypic context: association of DPB1 and HLA class I loci among DR3- and DR4-matched Italian patients and controls.
    Noble JA, Martin A, Valdes AM, Lane JA, Galgani A, Petrone A, Lorini R, Pozzilli P, Buzzetti R, Erlich HA.
    Hum Immunol; 2008 Sep 20; 69(4-5):291-300. PubMed ID: 18486765
    [Abstract] [Full Text] [Related]

  • 5. The [HLA-B18, F1C30, DR3] conserved extended haplotype carries a susceptibility gene for IgD deficiency.
    Calvo B, Castaño L, Marcus-Bagley D, Fici DA, Awdeh Z, Alper CA.
    J Clin Immunol; 2000 May 20; 20(3):216-20. PubMed ID: 10941830
    [Abstract] [Full Text] [Related]

  • 6. Tumor necrosis factor-associated susceptibility to type 1 diabetes is caused by linkage disequilibrium with HLA-DR3 haplotypes.
    Kumar N, Kaur G, Tandon N, Mehra N.
    Hum Immunol; 2012 May 20; 73(5):566-73. PubMed ID: 22366579
    [Abstract] [Full Text] [Related]

  • 7. High-risk genotypes HLA-DR3-DQ2/DR3-DQ2 and DR3-DQ2/DR4-DQ8 in co-occurrence of type 1 diabetes and celiac disease.
    Smigoc Schweiger D, Mendez A, Kunilo Jamnik S, Bratanic N, Bratina N, Battelino T, Brecelj J, Vidan-Jeras B.
    Autoimmunity; 2016 Jun 20; 49(4):240-7. PubMed ID: 27138053
    [Abstract] [Full Text] [Related]

  • 8. An influence of HLA-A, B, DR, DQ, and MICA on the occurrence of Celiac disease in patients with type 1 diabetes.
    Bratanic N, Smigoc Schweiger D, Mendez A, Bratina N, Battelino T, Vidan-Jeras B.
    Tissue Antigens; 2010 Sep 20; 76(3):208-15. PubMed ID: 20492597
    [Abstract] [Full Text] [Related]

  • 9. A high frequency of the A30, B18, DR3, DRw52, DQw2 extended haplotype in Sardinian celiac disease patients: further evidence that disease susceptibility is conferred by DQ A1*0501, B1*0201.
    Congia M, Frau F, Lampis R, Frau R, Mele R, Cucca F, Muntoni F, Porcu S, Boi F, Contu L.
    Tissue Antigens; 1992 Feb 20; 39(2):78-83. PubMed ID: 1349446
    [Abstract] [Full Text] [Related]

  • 10. The frequent and conserved DR3-B8-A1 extended haplotype confers less diabetes risk than other DR3 haplotypes.
    Baschal EE, Aly TA, Jasinski JM, Steck AK, Johnson KN, Noble JA, Erlich HA, Eisenbarth GS, Type 1 Diabetes Genetics Consortium.
    Diabetes Obes Metab; 2009 Feb 20; 11 Suppl 1(Suppl 1):25-30. PubMed ID: 19143812
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Extended DR3-D6S273-HLA-B haplotypes are associated with increased susceptibility to type 1 diabetes in US Caucasians.
    Valdes AM, Wapelhorst B, Concannon P, Erlich HA, Thomson G, Noble JA.
    Tissue Antigens; 2005 Jan 20; 65(1):115-9. PubMed ID: 15663750
    [Abstract] [Full Text] [Related]

  • 13. A collaborative European search for non-DQA1*05-DQB1*02 celiac disease loci on HLA-DR3 haplotypes: analysis of transmission from homozygous parents.
    Louka AS, Moodie SJ, Karell K, Bolognesi E, Ascher H, Greco L, Momigliano-Richiardi P, Partanen J, Ciclitira PJ, Sollid LM, European Genetics Cluster on Celiac Disease.
    Hum Immunol; 2003 Mar 20; 64(3):350-8. PubMed ID: 12590980
    [Abstract] [Full Text] [Related]

  • 14. HLA class II susceptibility pattern for type 1 diabetes (T1D) in an Iranian population.
    Kiani J, Hajilooi M, Furst D, Rezaei H, Shahryari-Hesami S, Kowsarifard S, Zamani A, Solgi G.
    Int J Immunogenet; 2015 Aug 20; 42(4):279-86. PubMed ID: 26088816
    [Abstract] [Full Text] [Related]

  • 15. Common HLA-B8-DR3 haplotype in Northern India is different from that found in Europe.
    Witt CS, Price P, Kaur G, Cheong K, Kanga U, Sayer D, Christiansen F, Mehra NK.
    Tissue Antigens; 2002 Dec 20; 60(6):474-80. PubMed ID: 12542740
    [Abstract] [Full Text] [Related]

  • 16. When type 1 diabetes meets celiac disease.
    Vidan-Jeras B.
    HLA; 2018 Dec 20; 92 Suppl 2():64-66. PubMed ID: 30488586
    [Abstract] [Full Text] [Related]

  • 17. Additional factor in some HLA DR3/DQ2 haplotypes confers a fourfold increased genetic risk of celiac disease.
    Bolognesi E, Karell K, Percopo S, Coto I, Greco L, Mantovani V, Suoraniemi E, Partanen J, Mustalahti K, Mäki M, Momigliano-Richiardi P.
    Tissue Antigens; 2003 Apr 20; 61(4):308-16. PubMed ID: 12753669
    [Abstract] [Full Text] [Related]

  • 18. Serological and molecular studies of HLA in insulin-dependent diabetes mellitus in Sardinia.
    La Nasa G, Carcassi C, Cirillo R, Mulargia M, Leone AL, Vacca A, Pizzati A, Boero R, Arras M, Porcella R.
    Dis Markers; 1990 Apr 20; 8(6):333-40. PubMed ID: 2101347
    [Abstract] [Full Text] [Related]

  • 19. Linkage disequilibrium with predisposing DR3 haplotypes accounts for apparent effects of tumor necrosis factor and lymphotoxin-alpha polymorphisms on type 1 diabetes susceptibility.
    Noble JA, Valdes AM, Lane JA, Green AE, Erlich HA.
    Hum Immunol; 2006 Dec 20; 67(12):999-1004. PubMed ID: 17174749
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.